Medicus Pharma schedules webcast with Phase 2 trial investigator
Tweet Send to a Friend
Medicus Pharma Ltd. (NASDAQ: MDCX) announced that Dr. Babar K. Rao, the principal investigator of its SkinJect Phase 2 clinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
